NO822801L - Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner - Google Patents
Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furanerInfo
- Publication number
- NO822801L NO822801L NO822801A NO822801A NO822801L NO 822801 L NO822801 L NO 822801L NO 822801 A NO822801 A NO 822801A NO 822801 A NO822801 A NO 822801A NO 822801 L NO822801 L NO 822801L
- Authority
- NO
- Norway
- Prior art keywords
- furants
- disubstituted
- procedure
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT23546/81A IT1168163B (it) | 1981-08-18 | 1981-08-18 | Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative |
Publications (3)
Publication Number | Publication Date |
---|---|
NO822801L true NO822801L (no) | 1983-02-21 |
NO159448B NO159448B (no) | 1988-09-19 |
NO159448C NO159448C (no) | 1988-12-28 |
Family
ID=11208027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO822801A NO159448C (no) | 1981-08-18 | 1982-08-17 | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4431664A (no) |
JP (1) | JPS5859982A (no) |
KR (1) | KR860000851B1 (no) |
AR (1) | AR230444A1 (no) |
AT (1) | AT383597B (no) |
AU (1) | AU533719B2 (no) |
BE (1) | BE894093A (no) |
CA (1) | CA1182121A (no) |
CH (1) | CH650259A5 (no) |
DE (1) | DE3230265C2 (no) |
DK (1) | DK156067C (no) |
ES (1) | ES515068A0 (no) |
FR (1) | FR2511675A1 (no) |
GB (1) | GB2104071B (no) |
GR (1) | GR76260B (no) |
IT (1) | IT1168163B (no) |
LU (1) | LU84340A1 (no) |
NL (1) | NL186447C (no) |
NO (1) | NO159448C (no) |
PH (1) | PH19228A (no) |
PT (1) | PT75440B (no) |
SE (1) | SE448456B (no) |
ZA (1) | ZA825718B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1175808B (it) * | 1984-03-07 | 1987-07-15 | Ausonia Farma Srl | Procedimento per la preparazione di composto con attivita' antiulcera |
IT1196133B (it) * | 1984-06-06 | 1988-11-10 | Ausonia Farma Srl | Derivati furanici con attivita' antiulcera |
KR950009825B1 (ko) * | 1986-03-28 | 1995-08-29 | 자누스 화마스티씨 에스.알.엘. | 치료학적 항궤양 활성이 있는 니페로티딘의 합성방법 |
HU9203905D0 (en) * | 1989-04-05 | 1993-04-28 | Glaxo Group Ltd | Method for producing ranitidine |
JPH0416036U (no) * | 1990-05-31 | 1992-02-10 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140681A (en) * | 1974-11-08 | 1979-02-20 | Mitsubishi Chemical Industries, Limited | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
-
1981
- 1981-08-18 IT IT23546/81A patent/IT1168163B/it active
-
1982
- 1982-07-30 CH CH4612/82A patent/CH650259A5/it not_active IP Right Cessation
- 1982-08-04 AU AU86731/82A patent/AU533719B2/en not_active Ceased
- 1982-08-05 US US06/405,332 patent/US4431664A/en not_active Expired - Fee Related
- 1982-08-06 ZA ZA825718A patent/ZA825718B/xx unknown
- 1982-08-09 DK DK357182A patent/DK156067C/da not_active IP Right Cessation
- 1982-08-11 NL NLAANVRAGE8203160,A patent/NL186447C/xx not_active IP Right Cessation
- 1982-08-12 CA CA000409313A patent/CA1182121A/en not_active Expired
- 1982-08-12 SE SE8204670A patent/SE448456B/sv not_active IP Right Cessation
- 1982-08-12 BE BE2/59796A patent/BE894093A/nl not_active IP Right Cessation
- 1982-08-13 GB GB08223316A patent/GB2104071B/en not_active Expired
- 1982-08-13 PH PH27729A patent/PH19228A/en unknown
- 1982-08-13 JP JP57141602A patent/JPS5859982A/ja active Granted
- 1982-08-13 GR GR69044A patent/GR76260B/el unknown
- 1982-08-13 FR FR8214079A patent/FR2511675A1/fr active Granted
- 1982-08-14 DE DE3230265A patent/DE3230265C2/de not_active Expired
- 1982-08-17 KR KR8203689A patent/KR860000851B1/ko active
- 1982-08-17 AT AT0312282A patent/AT383597B/de not_active IP Right Cessation
- 1982-08-17 NO NO822801A patent/NO159448C/no unknown
- 1982-08-17 ES ES515068A patent/ES515068A0/es active Granted
- 1982-08-18 AR AR290336A patent/AR230444A1/es active
- 1982-08-18 PT PT75440A patent/PT75440B/pt not_active IP Right Cessation
- 1982-08-18 LU LU84340A patent/LU84340A1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO156940C (no) | Anlogifremgangsmte til fremstilling av terapeutisk aktive cis, endo-2-azabicyklo-(3.3.0)-oktan-3-karboksylsyrer. | |
NO154905C (no) | Fremgangsmaate for fremstilling av preparater for behandling av melanomer. | |
NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
NO158021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat. | |
NO162022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater. | |
NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
NO166327C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
NO158419C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner. | |
NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
NO810675L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
NO164168C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser. | |
NO814424L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser. | |
NO158183C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner. | |
NO166326C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater. | |
NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
NO161177C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere. | |
NO154795C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater. | |
NO164417C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater. | |
NO154494C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner. | |
NO822801L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner | |
NO157421C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3,7-diazabicyclo-(3.3.1)-nonan-derivater. |